Replies to post #6587 on InMed Pharmaceuticals Inc (INM)

[Matilda1]

I don’t have any problem at all with your critiques of the Company, it’s the childish personal attacks we can do without.

Most of us here have been invested at a much lower average than the current price, but yes no updates and constant pushback of trials are testing my patience.

[lesgetrich]

there was no justification for a pop in pps to $1, let alone $1.95 except for shady insider moves

I would remind you that when InMed reached those levels last January the expectation was that clinical trials would begin in spring of 2018. That expectation was set back by a year months ago. I expect we'll have a similar uptick again this coming January.